A randomized phase II trial of TG4001 plus avelumab versus avelumab alone in recurrent/metastatic (R/M) human papilloma virus (HPV)-16 positive anogenital cancers

C. Le Tourneau et al.
AACR 2023
Download the poster here
Poster Presentation